There is a strong genetic link - a baby is 30-40 times more likely to develop cleftlip and palate if their elder brother or sister was also born with the condition.
One of the ingredients in Qsymia is topiramate, an anti-convulsant that has been linked to birth defects such as cleftlip and cleftpalate in babies born to women who have taken it for migraines or seizures.